Vivimed Labs’ FDF facility in Jeedimetla gets renewed GMP approval from Ukraine
The GMP approval also includes five new product registrations
Vivimed Labs, a niche Specialty Chemicals and Pharmaceuticals company, announced that its FDF manufacturing facility located in Jeedimetla, near Hyderabad inspected in August 2017 by the Ukraine Ministry of Health, has been approved and accredited with GMP Certification effective September 2017 and same has been renewed up to 04.02.2022 on 10.02.2021. Ukraine is a member Country of PICS, whose members include many European Countries.
The GMP approval extension also includes five new product registrations.
Commenting on the approval/renewal, Ramesh Krishnamurthy, CEO of Vivimed Labs said, “Successful renewal of PICS GMP Certification enables Vivimed to scale up its branded product distribution in CIS Countries. Export thrust is key contributor to the growth strategy of Vivimed”.